Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

359 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer Therapy Due to Apoptosis: Galectin-9.
Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T. Fujita K, et al. Among authors: hirashima m. Int J Mol Sci. 2017 Jan 1;18(1):74. doi: 10.3390/ijms18010074. Int J Mol Sci. 2017. PMID: 28045432 Free PMC article. Review.
Galectin-9 in cancer therapy.
Fujihara S, Mori H, Kobara H, Rafiq K, Niki T, Hirashima M, Masaki T. Fujihara S, et al. Among authors: hirashima m. Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):130-7. doi: 10.2174/1872214811307020006. Recent Pat Endocr Metab Immune Drug Discov. 2013. PMID: 23514536 Review.
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.
Fujita K, Iwama H, Sakamoto T, Okura R, Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Yamana Y, Himoto T, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T. Fujita K, et al. Among authors: hirashima m. Int J Oncol. 2015;46(6):2419-30. doi: 10.3892/ijo.2015.2941. Epub 2015 Mar 30. Int J Oncol. 2015. PMID: 25823465
MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M, Morishita A, Sakamoto T, Katsura A, Kato K, Nishioka T, Toyota Y, Fujita K, Maeda E, Nomura T, Tani J, Miyoshi H, Yoneyama H, Kobara H, Fujiwara S, Nishiyama N, Iwama H, Himoto T, Hirashima M, Masaki T. Miyata M, et al. Among authors: hirashima m. Int J Oncol. 2015 Aug;47(2):535-42. doi: 10.3892/ijo.2015.3036. Epub 2015 Jun 5. Int J Oncol. 2015. PMID: 26060089
Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
Takano J, Morishita A, Fujihara S, Iwama H, Kokado F, Fujikawa K, Fujita K, Chiyo T, Tadokoro T, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Kobara H, Mori H, Niki T, Hirashima M, Masaki T. Takano J, et al. Among authors: hirashima m. Oncol Rep. 2016 Feb;35(2):851-60. doi: 10.3892/or.2015.4452. Epub 2015 Nov 26. Oncol Rep. 2016. PMID: 26717877
Galectin-9: An anticancer molecule for gallbladder carcinoma.
Tadokoro T, Morishita A, Fujihara S, Iwama H, Niki T, Fujita K, Akashi E, Mimura S, Oura K, Sakamoto T, Nomura T, Tani J, Miyoshi H, Yoneyama H, Himoto T, Hirashima M, Masaki T. Tadokoro T, et al. Among authors: hirashima m. Int J Oncol. 2016 Mar;48(3):1165-74. doi: 10.3892/ijo.2016.3347. Epub 2016 Jan 19. Int J Oncol. 2016. PMID: 26797414
Galectin‑9 ameliorates fulminant liver injury.
Tadokoro T, Morishita A, Sakamoto T, Fujihara S, Fujita K, Mimura S, Oura K, Nomura T, Tani J, Yoneyama H, Iwama H, Himoto T, Niki T, Hirashima M, Masaki T. Tadokoro T, et al. Among authors: hirashima m. Mol Med Rep. 2017 Jul;16(1):36-42. doi: 10.3892/mmr.2017.6606. Epub 2017 May 18. Mol Med Rep. 2017. PMID: 28534962 Free PMC article.
Correlation between serum galectin-9 levels and liver fibrosis.
Fujita K, Niki T, Nomura T, Oura K, Tadokoro T, Sakamoto T, Tani J, Yoneyama H, Morishita A, Kuroda N, Arai T, Nishimoto N, Himoto T, Hirashima M, Masaki T. Fujita K, et al. Among authors: hirashima m. J Gastroenterol Hepatol. 2018 Feb;33(2):492-499. doi: 10.1111/jgh.13851. J Gastroenterol Hepatol. 2018. PMID: 28618039
359 results